Company / Current Liabilities
Crinetics Pharmaceuticals, Inc. Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$85.1M
FY2025
5-year range
$16.0M / $85.1M
FY2021-FY2025
Trend
+42.5%
vs FY2024
Sector context
#111 of 213
Health Care
What the data says
At $85M, Crinetics Pharmaceuticals, Inc.'s current liabilities ranks #103 of 213 in the Health Care sector. Current Liabilities has increased for 8 consecutive years, from $897,000 in FY2017 to $85M in FY2025.
Based on SEC 10-K filings.
$85M in FY2025 with a 5-year CAGR of +52.0%.
Increased from $44M to $85M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- +52.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 213 in Health CareTop 48% of 213This company $85.1M Sector average $1.6B
▼
-94.6% below sector average
Key checks
Key Insights
- Crinetics Pharmaceuticals, Inc.'s current liabilities has grown for 8 consecutive years.
- 5-year CAGR of +52.0%, indicating consistent growth.
- In FY2025, current liabilities increased 42.5% year-over-year.
- Ranks #111 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $85.1M | +42.5% |
| FY2024 | $59.7M | +35.8% |
| FY2023 | $43.9M | +58.5% |
| FY2022 | $27.7M | +73.3% |
| FY2021 | $16.0M | +52.5% |
| FY2020 | $10.5M | +25.8% |
| FY2019 | $8.3M | +5.2% |
| FY2018 | $7.9M | +783.5% |
| FY2017 | $897.0K | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026